Vor Biopharma Inc (VOR)
1.74
+0.05
(+2.96%)
USD |
NASDAQ |
Apr 29, 16:00
1.745
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Shareholders Equity (Quarterly): 150.72M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 150.72M |
| September 30, 2023 | 174.78M |
| June 30, 2023 | 204.45M |
| March 31, 2023 | 230.22M |
| December 31, 2022 | 250.61M |
| September 30, 2022 | 158.73M |
| June 30, 2022 | 174.97M |
| March 31, 2022 | 194.45M |
| Date | Value |
|---|---|
| December 31, 2021 | 216.26M |
| September 30, 2021 | 232.96M |
| June 30, 2021 | 250.11M |
| March 31, 2021 | 267.19M |
| December 31, 2020 | 48.27M |
| September 30, 2020 | 63.19M |
| December 31, 2019 | 7.64M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
7.64M
Minimum
Dec 2019
267.19M
Maximum
Mar 2021
174.97M
Average
194.45M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Masimo Corp | 1.365B |
| AnaptysBio Inc | 88.10M |
| Apellis Pharmaceuticals Inc | 194.52M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 198.13M |
| Total Liabilities (Quarterly) | 47.40M |